Novavax (NASDAQ:NVAX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.

Open	$8.05
Close	$7.99
Volume / Avg.	10.67M / 3.86M
Day Range	$7.80 - $8.54
52 Wk Range	3.81 - 23.86
Market Cap	$1.33B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	27.2%
Days to Cover	8.76

Recent News

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch (CORRECTED)

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye."

Erica Kollmann

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald Trump's executive order to withdraw from the global health body.

Kaustubh Bagalkote

Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all communications from the Centers for Disease Control and Prevention to stop.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.05
Close	$7.99
Volume / Avg.	10.67M / 3.86M
Day Range	$7.80 - $8.54
52 Wk Range	3.81 - 23.86
Market Cap	$1.33B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	27.2%
Days to Cover	8.76

About Novavax, Inc.

Sector

Health Care

Industry

Biotechnology

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical sta...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Novavax (NVAX) stock?

You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Novavax (NVAX) competitors?

Other companies in Novavax’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Novavax (NVAX) stock?

Novavax has a consensus price target of $48.13.

What is the current price for Novavax (NVAX)?

The stock price for Novavax (NASDAQ: NVAX) is $8.2717 last updated February 21, 2025 at 7:59 PM EST.

Does Novavax (NVAX) pay a dividend?

There are no upcoming dividends for Novavax.

When is Novavax (NASDAQ:NVAX) reporting earnings?

Novavax’s Q1 earnings are confirmed for Friday, May 9, 2025.

Is Novavax (NVAX) going to split?

There is no upcoming split for Novavax.

What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Novavax

Novavax (NVAX) Forecast